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ABSTRACT: Mutational analysis is widely used to study
the relationship between sequence and structure of
proteins and peptides. It is often assumed that substituting
a proline with another amino acid “locks” the peptide bond
in the trans conformation, allowing only a subset of the
initial molecular geometries to be observed. To test this
assumption, we assess the result of substituting two
prolines in the bradykinin sequence with alanine using
ﬁeld-asymmetric ion mobility spectrometry combined with
cryogenic ion spectroscopy in the gas phase. While the
structure of the mutant coincides with a part of the
conformational space of the original peptide, the higher
ﬂexibility of the alanine backbone compared to proline
allows it to access additional structures. We conclude that
proline-to-nonproline substitutions are helpful to assign
structures, but they should be used in conjunction with
spectroscopic techniques that allow detailed comparison of
the structures of the mutant and the native peptide.
Substituting an amino acid in a protein sequence withanother residue is often referred to as mutational analysis.1
This procedure reveals how critical a certain amino acid is for
the structure and function of a protein. In particular, it has been
used to study the role of proline as the only canonical amino
acid for which cis and trans isomers of the peptide bond are
comparable in energy.2 To assess the role of rare cis states
(5.2% according to Weiss and co-workers),3 the possibility of
isomerization can be eliminated by “locking” the Xxx-Pro bond
to the trans isomer via substituting the proline with another
amino acid.4,5
Mutational analysis, in conjunction with various methods of
structural determination, shows that proline performs multiple
functions within the protein sequence: It acts as a molecular
switch,6,7 and its isomerization is often a rate-limiting step in
protein folding.8,9 In order to deepen the understanding of the
structural role of proline, one can isolate a model system from
its native environment and apply powerful gas-phase tools that
can be implemented in a conformer-selective way. For example,
it was suggested that proline is one of the primary reasons for
the formation of distinct conformational families of short
peptides in the gas phase, resulting in multiple peaks in their
collisional-cross section (CCS) distributions determined by ion
mobility spectrometry (IMS).10−13 In order to establish a
correspondence between the features in the CCS distribution
and conformational preferences of prolyl-peptide bonds, the
same point mutations as in solution-phase studies have been
used.11,14−16 In the case of triply protonated bradykinin (BK),
for instance, three conformational families in the gas phase
were attributed to diﬀerent cis−trans isomers using proline-to-
alanine substitutions.15,17
It has been determined that protein secondary structure is
inﬂuenced by the presence of proline in two somewhat
orthogonal ways. On the one hand, proline disrupts helix and β-
sheet formation and increases the level of backbone disorder.18
On the other hand, it is conformationally restricted and makes
the protein backbone more rigid.19 If proline is substituted by
another amino acid, the resulting structure depends on the
interplay between these factors. Neverthless, mutational
analysis is often based on the assumption that upon “locking”
a peptide bond in the trans conformation, only a subset of the
initial molecular geometries should be observed.1,4,7,15,17,20−22
In this work we test this assumption for a mutant of bradykinin
using a combination of ion mobility spectrometry and double-
resonance, cryogenic-ion spectroscopy in the gas phase.
The experimental procedure is similar to that used
previously23 and is described in the Supporting Information.
Brieﬂy, we generate gas-phase ions by electrospray, separate
them into conformational families using ﬁeld asymmetric ion
mobility spectrometry (FAIMS),24 and inject them into a
home-built spectrometer, where we perform spectroscopic
studies at cryogenic temperatures.25
We have demonstrated previously that FAIMS allows us to
partially separate several conformational families of
BK3+(Figure 1a).23 Using cryogenic-ion spectroscopy as a
detector for a speciﬁc conformation, we observe that BK3+
forms at least three conformational families in the gas phase,
which we denoted I, II, and III.23 In this study we focus on
kinetically trapped conformational families I and II observed
directly after ESI with low collisional activation and preserved
upon FAIMS separation.
Normal bradykinin includes prolines in positions 2, 3 and 7,
and the barriers for cis−trans isomerization are considered to be
the origin of distinct conformational families in the gas
phase.15,17 Here we explore the conformational space of triply
protonated Pro3&7 → Ala mutant of BK with proline in
position 2. Pierson and co-workers suggested that this mutant
reproduces the structure of conformational family B of native
BK, separated by the drift tube IMS.17
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The CV distribution of this mutant in the gas phase (black
trace, Figure 1b) exhibits maxima at −8.2 V and −7.1 V. A part
of it, which lies below ∼ −7 V, overlaps with that of
nonsubstituted bradykinin (Figure 1a), but signiﬁcant ion
signal appears at CV values between −7 V to −4 V.
To distinguish the conformational families of Pro3&7→ Ala,
we set the CV on the shoulders of the distribution (−8.3 V and
−6.0 V) and record UV photofragmentation spectra (Figure 2).
Three intense bands, labeled 1−3, appear only at CV = −6.0 V,
while the band labeled 4 is unique to the photofragmentation
spectrum recorded at CV = −8.3 V.
The CV distribution of the Pro3&7 → Ala mutant can be
separated into two main components by detecting selectively
the photofragmentation signal on one absorption at a time
(Figure 1b). The CV distributions corresponding to peaks 2
and 6 of the UV photofragment spectrum are shown; all others
fall within one of the two presented. We thus observe that the
conformational space of Pro3&7 → Ala mutant consists of two
main conformational families that appear at diﬀerent character-
istic compensation voltages.
The CV distributions of the Pro3&7 → Ala mutant and
nonsubstituted BK partially overlap. The maximum for
conformational family II of BK lies at CV = −8.0 V, while
for the mutant we ﬁnd a conformational family with a
maximum at CV = −8.3 V. To gain further insight into the
relation between the structures of BK and the mutant, we
compare the UV photofragmentation spectra of their over-
lapping conformational families (Figure 3). The spectra are
similar: two major bands of conformer 5 correspond to those of
conformer α; the same holds for conformers 6 and β. However,
a band appears in the photofragmentation spectrum of the
mutant at 37439.2 cm−1, which corresponds to conformer 4
and is not present in the case of nonsubstituted BK.
The strongly similar pattern of UV bands shown in Figure 3
suggests that conformational family II of nonsubstituted BK is
present among molecular geometries adopted by Pro3&7 →
Ala. At the same time, the mutant also forms conformer 4,
which appears at the same CV as conformational family II of
BK3+, but has a diﬀerent structure. To conﬁrm these
conclusions, we compare the vibrational spectra of all
conformers mentioned above (Figure 4). The spectra of
conformers 6 of the mutant and β of BK3+ are remarkably
similarall the major bands are at the same positionwhich
Figure 1. (a) CV distribution of BK3+ detecting all transmitted ions
(black) and recorded via UV transitions unique for conformational
families I and II. (b) CV distribution of Pro3&7 → Ala mutant
detecting all transmitted ions (black) and recorded via UV transitions
2 (pink) and 6 (blue) in Figure 2.
Figure 2. UV photofragmentation spectra of Pro3&7 → Ala mutant
with the CV value set to (a) −6.0 V and (b) −8.3 V.
Figure 3. Comparison between UV photofragmentation spectra of
Pro3&7→ Ala mutant at CV = −8.3 V and conformational family II of
BK3+ at CV = −7.0 V. This CV value for BK is chosen to avoid spectral
contamination from family I. The conformers identiﬁed by IR-UV
double resonance spectroscopy are labeled.
Figure 4. Comparison of vibrational spectra of conformers 4, 5, and 6
of Pro3&7 → Ala mutant and conformers α and β of nonsubstituted
BK3+. The dashed line indicates the band of conformer 6 that shifts
upon the mutation. We use isotopic labeling to identify this band as
the serine NH stretch (Figure S1).
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suggests that these two essentially share the same structure. We
expect two additional bands to appear in the NH stretch region
of the mutant, since substituting two prolines with alanine
increases the number of amide NH groups by two. These may
be responsible for the shoulders on the peak at 3458 cm−1 or
the additional intensity in the group of peaks near 3385 cm−1.
The spectra of conformers 5 of the mutant and α (conforma-
tional family II of BK3+) suggest that these also share essentially
the same geometry.
The vibrational spectrum (and hence the structure) of
conformer 4 of the mutant is substantially diﬀerent from that of
any structure adopted by native BK3+, despite their overlapping
CV distributions. The two bands in the region higher than 3550
cm−1 do not overlap with those of conformer α, and the pattern
of features in the 3380−3490 cm−1 region seems to be clearly
distinct.
To summarize, we observe that the Pro3&7 → Ala mutant
forms two conformational families in the gas phase. One of
them overlaps with conformational family II of native BK, and
both conformers α and β of this family are reproduced by the
mutant. This implies that prolines 3 and 7 in these two
conformers of native BK are in the trans conﬁguration.
Conformers 1−4 of Pro3&7 → Ala are not accessible in
nonsubstituted BK: Structures 1−3 appear at CV values higher
than those recorded for BK and have distinct features in the
electronic absorption spectrum, while conformer 4 has a
distinct IR signature, which reﬂects substantial diﬀerences in
the structure.
We compared these ﬁndings with the information obtained
by drift-tube (DT) IMS. As reported by Clemmer and co-
workers,17 the drift-time distribution of BK3+ has three resolved
peaks, A, B and C, while the drift-time distribution of Pro3&7
→ Ala appears as one peak, which partially overlaps with family
B of nonsubstituted BK (Figure S2). We preselected family B in
a DT analogous to the one used by Clemmer, measuring its
vibrational spectrum using H2-tagging
26 and comparing it with
the infrared spectra of conformers α and β (Figure S4). This
shows that conformational family B consists mostly of
conformers α and β. In other words, conformational family II
separated by FAIMS corresponds to family B isolated by DT-
IMS.
Our ﬁndings imply that underneath one peak in the mutant
CCS distribution there are more conformations than within
family B/II of nonsubstituted BK. To exclude the possibility
that they arise from collisional heating in the FAIMS device, we
measured the electronic absorption spectrum of the mutant
with minimal collisional activation without FAIMS separation
(Figure 5). Conformations 2 and 4 are present even when the
activation is minimized. Moreover, if conformers 1−4 resulted
from collisional heating, it would be possible to produce them
via intentional activation in the drift tube. However, when
increasing the voltage in the activation region of the DT, we do
not observe any new peaks in the arrival-time distribution of
the Pro3&7 → Ala mutant (Figure S3). We conclude that an
additional conformational family with similar CCS appears
upon mutation.
To explain why we observe additional conformers, we turn to
statistical analysis of protein structures. It is well-known that the
local structure of a peptide is determined by three dihedral
angles, usually denoted as φ, ψ, and ω. The angle ω can take
two discrete values: around 180° in the trans conformation or
around 0° in the cis. Obviously, the conformational preferences
of proline and alanine relative to other dihedral angles are also
important. Chakrabarti and co-workers analyzed a database of
408 polypeptide chain structures and presented all torsion
angles in Ramachadran plots (Figure S5).27 They clearly show
that the alanine backbone can occupy a signiﬁcantly larger part
of the conformational space and adopt structures that are not
achievable for the proline residue due to the nature of its side
chain.
In the case of BK, we observe nearly identical conformations
for the alanine-substituted and nonsubstituted peptide, but this
does not have to be the case. It is possible that substitution of
proline by alanine energetically favors structures with the
torsion angles φ and ψ forbidden for proline-containing
molecule. In such a case, proline-to-alanine substitution will
not provide information about the cis−trans isomerization state
of the native peptide. This type of behavior has been recently
observed when applying mutational analysis to protein
oligomerization regulation.28
Proline-to-alanine substitution has allowed us to identify two
conformations of native BK3+ in the gas phase that have
prolines in positions 3 and 7 in the trans conﬁguration; thus, in
this case the aim of mutational analysis could be realized.
However, we ﬁnd that the Pro3&7→ Ala mutant does not only
reproduce a part of the conformational space of BK3+, as it is
often assumed, but also forms additional structures due to the
higher ﬂexibility of alanine compared to proline. This fact
renders proline mutational analysis prone to inexact con-
clusions when used in conjunction with low-resolution
structure determination techniques. Our ﬁndings can be
important when using mutational analysis for elucidating the
role of proline in such phenomena as transmembrane loops,
intrinsically disordered proteins, or amyloidosis.
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